GlassScriptPhysician profile
Nirav J Shah
NPI 1255531182
$126,733.74
in general payments reported to CMS, 2019-2025
23 companies · $37K in 2025
The $37K reported for 2025 was more than what 86% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,164 · 2021: $19K · 2022: $10K · 2023: $1,281 · 2024: $39K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Travel and Lodging: $13K · Education: $3,600 · Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,312.00 |
| Travel and Lodging | $12,668.85 |
| Education | $3,600.00 |
| Food and Beverage | $3,073.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $69,812.55 | 2021-2025 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $49,743.79 | 2019-2025 | G7, Avenir, Persona |
| Insight Medical Systems, INC. | $2,798.76 | 2024 | Arvis |
| Smith+Nephew, INC. | $1,479.36 | 2019-2021 | |
| Depuy Synthes Sales INC. | $626.24 | 2019-2021 | |
| Stryker Corporation | $605.05 | 2020-2025 | Na, Triathlon |
| Saxum Surgical, INC. | $439.91 | 2022-2023 | |
| Team_makena_llc | $362.73 | 2019-2021 | |
| Medical Device Business Services, INC. | $171.21 | 2023 | |
| Abbott Laboratories | $148.84 | 2021-2024 | Proclaim |
| Innovation Technologies INC | $129.76 | 2022-2024 | Irrisept |
| Intuitive Surgical, INC. | $96.65 | 2022 | |
| Medtronic USA, INC. | $53.96 | 2019 | |
| Phathom Pharmaceuticals, INC. | $53.90 | 2024-2025 | Voquezna |
| Bioventus LLC | $44.74 | 2023 | Durolane |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $44.21 | 2022-2024 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $30.47 | 2025 | |
| Carbofix Orthopedics INC | $21.47 | 2023 | |
| Kci USA, INC. | $16.83 | 2021 | |
| Acera Surgical, INC. | $15.24 | 2024 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $14.71 | 2021 | |
| Biolase, INC. | $12.00 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.